• share
• favorite_border

Cell Therapy for Brain Tumors: Foundation Hosts Focused Ultrasound Roundtable

• share
• favorite_border

The Focused Ultrasound Foundation today announced a historic achievement for the field of noninvasive medicine: more than one million patients worldwide have now been treated with focused ultrasound.

• share
• favorite_border

A molecule called glial fibrillary acidic protein (GFAP) rose significantly in the blood of patients who underwent high-intensity focused ultrasound (HIFU), a procedure that is used to treat tremors and causes damage similar to a small stroke, UT Southwestern Medical Center scientists discovered in a new study. Their findings, published in Brain Communications, reveal a potential biomarker for stroke and could eventually lead to blood tests that quickly diagnose brain injuries.

• share
• favorite_border

• share
• favorite_border

A New Mexico family gets life-saving care for their newborn daughter at UCLA Health.

• share
• favorite_border

The Focused Ultrasound Foundation has designated Columbia University as a Focused Ultrasound Center of Excellence, recognizing its leadership in research and innovation. Columbia University is the 7th Center of Excellence in the US and the 14th worldwide.

• share
• favorite_border

Results from a clinical trial using focused ultrasound to treat Alzheimer鈥檚 disease were published today in the Journal of Neurosurgery, representing a critically important new direction in the treatment of this disease.

• share
• favorite_border

Releasing a drug selectively in specific locations in the body, including the brain, has been challenging. Researchers at the University of Utah have tackled the problem by designing ultrasound-sensitive nanoparticles that release a drug at the targeted site when activated by focused ultrasound.

• share
• favorite_border

Computed tomography (CT) has long been a cornerstone of modern imaging, providing detailed 3D insights into the human body and other materials. However, conventional CT requires hundreds of X-ray projections from multiple angles, exposing patients to significant radiation doses and relying on large, immobile systems.

• share
• favorite_border

Researchers have developed a compact, wearable ultrasound device that monitors muscle activity. Attachable to the skin with an adhesive and powered by a small battery, the device wirelessly captures high-resolution images of muscle movements, enabling continuous, long-term monitoring. When worn on the rib cage, it effectively monitored diaphragm function for respiratory health assessments. When worn on the forearm, it accurately captured hand gestures, allowing users to control a robotic arm and even navigate virtual games. This new technology has potential applications in healthcare for conditions affecting muscle function, as well as in human-machine interfaces for more natural robotic control.

• share
• favorite_border

Announcement of contents of the September 2024 issue of Neurosurgical Focus

• share
• favorite_border

A new Harvey L. Neiman Health Policy Institute study found the geographic distance to facilities providing breast MR or ultrasound was more than 2.7 times further than the distance to a mammography center. Given new breast density guidelines, now approximately one in two women (those who have dense breast tissue) are recommended to have supplemental breast cancer screening by breast MR or ultrasound due to their relatively higher breast cancer risk. The research, published in the American Journal of Preventive Medicine, measured distance to the nearest facility offering mammography, breast MR and/or breast ultrasound for 29,629 ZIP codes. The researchers compared distance between imaging types to reveal the relative extent of this barrier to access and to inform approaches to mitigate disparities.

• share
• favorite_border

Researchers at seven academic medical institutions around the United States held a multicenter clinical trial, finding that bilateral focused ultrasound treatment is safe for patients who had previously undergone treatment for essential tremor. Clinical data from the trial was used for the approval of bilateral focused ultrasound thalamotomy by the US Food and Drug Administration.

• share
• favorite_border

A collaborative team of NIH-funded researchers is developing a way to obtain DNA shed from brain tumors using focused ultrasound. Their first-in-human study could be an important step towards improving the way brain tumors are diagnosed.

• share
• favorite_border

Stay informed! These are the latest research articles on "Long COVID" from the Coronavirus 麻豆传媒 Source on 麻豆传媒.